Websites/Resources to Expand Advancements of Drug Development

MPP and Unitaid Intellectual Property Report on Long-Acting Technologies

Unitaid and the Medicines Patent Pool have worked together to develop a brief overview of the intellectual property status of long-acting drugs, formulation processes and delivery devices for major infectious diseases that are in pre-clinical or later stages of development as of October 2018.

Health Topics:

HIV

Tuberculosis

Viral Hepatitis

Global Accelerator for Paediatric Formulations (GAP-f)

The Global Accelerator for Paediatric Formulations (GAP-f) aims to accelerate pediatric drug development, fit-for-purpose formulation development, and product access and uptake.

Health Topics:

HIV

Pediatric Formulations

Target Product Profile for Future LA/ER ARVs

A table outlining a target product profile for long-acting, extended-release ARVs

Health Topics:

HIV